4//SEC Filing
Stehman-Breen Catherine 4
Accession 0000950170-24-064729
CIK 0001818794other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:10 PM ET
Size
5.2 KB
Accession
0000950170-24-064729
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock option (right to buy)
2024-05-22+25,133→ 25,133 totalExercise: $31.53Exp: 2034-05-21→ Common Stock (25,133 underlying)
Footnotes (1)
- [F1]This option was granted on May 22, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 22, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to continued service.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001702233
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:10 PM ET
- Size
- 5.2 KB